Stimulation therapies for Parkinson's disease: Over the past two decades;La maladie de Parkinson, les traitements par stimulation: Vingt ans d'expérience

Bulletin de l'Academie Nationale de Medecine

Volumn 194, Issue 7, 2010, Pages 1273-1286

  Benabid, Alim Louis ^a  

^a NONE

Author keywords

Basal ganglia; Deep brain stimulation; Parkinson

Indexed keywords

EID: 79955792634     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32208-3     Document Type: Conference Paper

References (34)

1. OHYE C., MAEDA T., NARABAYASHI H. -Physiologically defined Vim nucleus. Its special reference to control of tremor. Appl Neurophysiol, 1977, 39, 285-295.
2. BENABID A.L., POLLAK P., GROSS C., et al. -Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct. Neurosurg, 1994, 62, 76-84.
3. LIMOUSIN P, POLLAK P, BENAZZOUZ A, et al. -Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 1995, 345, 91-95.
4. DEUSCHL G, SCHADE-BRITTINGER C, KRACK P, et al. A randomised trial of deep-brain stimulation for Parkinson's diseased Engl. J. Med., 2006,355,896-908. Erratum in: N. Engl. J. Med, 2006, 355, 1289.
5. SVENNILSON E, TORVIK A, LOWE R, et al. -Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr. Neurol. Scand, 1960, 55, 358-377.
6. LAITINEN L.V., BERGENHEIM A.T., HARIZ M. -Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg, 1992, 76, 53-61.
7. SIEGFRIED J., LIPPITZ B. -Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. J. Neurosurgery, 1994, 35, 1126-1130.
8. LIMOUSIN-DOWSEY P., POLLAK P., VAN BLERCOM N., et al. -Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease J. Neurol., 1999, 246 [Suppl 2], II/42-45.
9. BERGMAN H, WICHMANN T, DELONG MR. -Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 1990, 249, 1436-1438.
10. AZIZ TZ, PEGGS D, SAMBROOK MA, et al. -Lesion of the subthalamic nucleus for the alleviation of l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Dis., 1991, 6, 288-292.
11. KRACK P, BATIR A, VAN BLERCOM N, et al. -Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med., 2003, 349, 1925-1934.
12. JAHANSHANHI M, ARDOUIN CM, BROWN RG, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain. 2000, 123, 1142-54.
13. THOBOIS S, ARDOUIN C, LHOMMEE E, et al-Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain, 2010, 133, 1111-27.
14. JENKINSON N, NANDI D, MIALL RC, et al -Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport, 2004, 15, 2621-2624.
15. MAZZONE P, LOZANO A, STANZIONE P, et al- Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport, 2005, 16, 1877-1881.
16. FERRAYE MU, DEBU B, FRAIX V, et al. -Brain, 2010, 133 (Pt 1), 205-14.
17. ARNULF I, FERRAYE M, FRAIX V, et al. -Sleep induced by stimulation in the human pedunculopontine nucleus area. Ann Neurol, 2010, 67 (4), 546-9.
18. FOLLETT KA, WEAVER FM, STERN M, et al. -Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N. Engl J. Med, 2010, 362, 2077-91.
19. JAVOY-AGID F, HIRSCH EC, DUMAS S, et al. -Decreased tyrosine hydroxylase messenger RNA in the survivmgdopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neurosci., 1990, 38, 245-53.
20. PIALLAT B, BENAZZOUZ A, BENABID AL. -Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur., J., Neurosci, 1996, 8, 1408-1414.
21. WALLACE BA, ASHKAN K, HEISE CE, et al. -Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain, 2007, 130, 2129-2145. Epub 2007 Jun 20.
22. PORTMAN AT, VAN LAAR T, STAAL MJ et al. -Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease. Parkinsonism Relat. Disord, 2006, 12, 143-8.
23. XIA R, BERGER F, PIALLAT B, et al. -Alteration of Hormone and Neurotransmitter Production in Cultured Cells by High and Low Frequency Electrical Stimulation Acta Neurochir., (Wien), 2007, 149, 67-73, discussion 73.
24. CAMARON C., MCINTYRE, WARREN M. et al. -Cellular Effects of Deep Brain Stimulation: Model-Based Analysis of Activation and Inhibition. J. Neurophysiol, 2004, 91, 1457-1469.
25. KÜHN AA, FOGELSON N, LIMOUSIN PD, et al. -Frequency-specific effects of stimulation of the subthalamic area in treated Parkinson's disease patients. Neuroreport, 2009, 20, 975-8.
26. PIALLAT B., POLOSAN M., FRAIX V, et al. -Subthalamic neuronal firing in obsessivecompulsive disorder and Parkinson disease. Ann, Neurol., 2010 Dec 28, [Epub ahead of print]
27. GRADINARU V., MOGRI M., THOMPSON KR, et al -Optical Deconstruction of Parkinsonian Neural Circuitry, Science, 2009, 324, 354-9. Epub 2009 Mar 19.
28. DROUOT X., OSHINO S., JARRAYA B., et al. -Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron., 2004, 44, 769-778.
29. FUENTES R., PETERSSON P., SIESSER WB, et al. -Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science, 2009, 323, 1578-82.
30. THEVATHASAN W, MAZZONE P, JHA A, et al. -Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology, 2010, 74, 1325-7. No abstract available.
31. YOUNG CK, KOKE SJ, KISS ZH, et al. -Deep brain stimulation of the posterior hypothalamic nucleus reverses akinesia in bilaterally 6-hydroxydopamine-lesioned rats. Neuroscience, 2009, 162, 1-4.
32. KAPLITT MG, FEIGIN A, TANG C, et al. -Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet, 2007, 369, 2097-2105.
33. MARKS WJ JR, BARTUS RT, SIFFERT J, et al. -Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol., 2010, 9, 1164-72. Epub 2010 Oct 20.
34. JARRAYA S., BOULET S., RALPH GS., et al. -Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Sci. Transi Med, 2009, 2, 2ra4 ()